Improving Lives with Precision Diagnostics
LabPMM GK is the Japanese subsidiary of Invivoscrive Inc., a US-based company headquartered in San Diego. We have obtained regulatory approval for the companion diagnostic test, "LeukoStrat CDx FLT3 Mutation Assay," for acute myeloid leukemia (AML) and have been manufacturing and selling standardized in vitro diagnostic kits domestically. Additionally, we have a commercial service lab that has received ISO 15189 certification and conducts LeukoStrat test service. We are actively advancing the development of genetic tests related to hematopoietic malignancies.
- Drug Discovery/Drug Discovery Support
- Commissioned Research/Analysis